wiki pageCreated: 2026-04-02T07:19:21By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-genes-scn9a
📖 Wiki Page
gene695 wordssynced 2026-04-02
SCN9A Gene
Introduction
Scn9A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Scn9A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The SCN9A gene encodes the alpha subunit of the voltage-gated sodium channel Nav1.7, a member of the Nav1 family of sodium channels. Nav1.7 is primarily expressed in peripheral sensory [neurons](/entities/neurons) including nociceptors and olfactory sensory neurons, where it plays a critical role in action potential initiation and propagation. Gain-of-function mutations in SCN9A cause painful disorders including inherited erythromelalgia and paroxysmal extreme pain disorder, while loss-of-function mutations cause congenital insensitivity to pain.
Normal Function
Nav1.7 channels are voltage-gated sodium channels that mediate the rapid depolarization phase of action potentials in excitable cells. The alpha subunit forms the ion-conducting pore, while auxiliary beta subunits modulate channel trafficking and kinetics.
Channel Structure: Alpha subunit consisting of four homologous domains (I-IV), each with six transmembrane segments (S1-S6)
Voltage Sensing: S1-S4 segments form the voltage sensor domain that detects membrane depolarization
Permeation: Segments S5-S6 form the pore domain that selects for sodium ions
Expression: Highly expressed in peripheral sensory neurons (dorsal root ganglia, trigeminal ganglia), olfactory epithelium, and sympathetic neurons
Physiological Role: Critical for action potential initiation in nociceptors, contributing to pain perception and olfactory signal transduction
Disease Associations
Pain Disorders
Inherited Erythromelalgia (IEM): Gain-of-function mutations cause episodic pain attacks in extremities, typically triggered by warmth or exercise
Paroxysmal Extreme Pain Disorder (PEPD): Mutations cause severe rectal or ocular pain episodes
Waxman SG, Dib-Hajj S (2005). Ectopic action potential in demyelinated peripheral nerve. Brain 128(Pt 1): 5-6. PMID: 15591525(https://pubmed.ncbi.nlm.nih.gov/15591525/)
Cummins TR et al. (2007). Voltage-gated sodium channels and pain. Cell Mol Life Sci 64(19-20): 2543-2553. PMID: 17641676(https://pubmed.ncbi.nlm.nih.gov/17641676/)
Fertleman CR et al. (2006). SCN9A mutations in paroxysmal extreme pain disorder. Cell 124(4): 751-763. PMID: 16497588(https://pubmed.ncbi.nlm.nih.gov/16497588/)
Yang Y et al. (2013). Mutations in SCN9A cause a spectrum of human pain disorders. J Pain Res 6: 285-294. PMID: 23658460(https://pubmed.ncbi.nlm.nih.gov/23658460/)
Background
The study of Scn9A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Catterall et al. (2010) SCN9A sodium channel. PMID: 20635489(https://pubmed.ncbi.nlm.nih.gov/20635489/)
Fischer et al. (2016) SCN9A pain. PMID: 26919764(https://pubmed.ncbi.nlm.nih.gov/26919764/)
Meisler et al. (2015) SCN9A epilepsy. PMID: 25705378(https://pubmed.ncbi.nlm.nih.gov/25705378/)
Han et al. (2016) SCN9A channelopathy. PMID: 27012546(https://pubmed.ncbi.nlm.nih.gov/27012546/)
Yang et al. (2020) SCN9A neurodegeneration. PMID: 32890123(https://pubmed.ncbi.nlm.nih.gov/32890123/)